Deferred Tax Assets, Operating Loss Carryforwards of Twist Bioscience Corp from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary: Twist Bioscience Corp quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Sep 2018 to 30 Sep 2025.
Twist Bioscience Corp Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Sep 2025 was $232,380,000, a 2.4% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)

Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Twist Bioscience Corp Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$232,380,000	+$5,421,000	+2.4%	30 Sep 2025	10-K	17 Nov 2025	2025	FY
Q3 2024	$226,959,000	+$17,621,000	+8.4%	30 Sep 2024	10-K	17 Nov 2025	2025	FY
Q3 2023	$209,338,000	+$18,001,000	+9.4%	30 Sep 2023	10-K	18 Nov 2024	2024	FY
Q3 2022	$191,337,000	+$27,555,000	+17%	30 Sep 2022	10-K	21 Nov 2023	2023	FY
Q3 2021	$163,782,000	+$51,348,000	+46%	30 Sep 2021	10-K/A	05 Jun 2023	2022	FY
Q3 2020	$112,434,000	+$39,093,000	+53%	30 Sep 2020	10-K	23 Nov 2021	2021	FY
Q3 2019	$73,341,000	+$23,540,000	+47%	30 Sep 2019	10-K	27 Nov 2020	2020	FY
Q3 2018	$49,801,000			30 Sep 2018	10-K	13 Dec 2019	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.